BioVersys AG
BioVersys AG is a drug Discovery founded in 2008.
2
Funding Rounds
$41.1m
Money raised
Funding series
Funding Series Analysis
The company BioVersys AG has raised a total of $41.1m in funding over 2 rounds.
Key Insights:
- BioVersys AG Series B round, September 2020: $20.1m
- BioVersys September 2020 Series B Funding Round: $21m
BioVersys AG Series B round, September 2020
$20.1m
BioVersys September 2020 Series B Funding Round
$21m
Industries
BioVersys AG is active in the following industries: